Human anti-GMI antibodies from patients with lower motor neuron disease or predominantly motor neuropathy recognize carbohydrate determinants shared by GM1 and related glycolipids and glycoproteins, but the identity of the antigens to which they bind in tissue is unknown. We examined the binding of
Cloning of human anti-GM1 antibodies from motor neuropathy patients
β Scribed by Dr. Hugh J. Willison; Gary Paterson; Peter G. E. Kennedy; Jean Veitch
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 1005 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
β¦ Synopsis
Copyright L? 1994 by the American Neurological Association 471 sera. We describe the basic biological properties of these antibodies in the context of their putative role in disease pathogenesis.
π SIMILAR VOLUMES
Low affinity anti-GM 1 IgM-antibodies are part of the normal repertoire of human plasma antibodies (Mizutamari et al.: J Neuroimmunol 50:215-220, 1994), a fact that is against the pathological role proposed for them in autoimmune diseases. Here we present evidence that these low affinity IgM-antibod
## Abstract High antibody affinity has been proposed as a disease determinant factor in neuropathies associated with antiβGM~1~ antibodies. An experimental model of GuillainβBarrΓ© syndrome, induced by immunization of rabbits with bovine brain gangliosides or GM~1~, was described recently (Yuki et a